Phase 2 N=126 Single-blind Treatment

Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate)

Healthy

Bottom Line

View on ClinicalTrials.gov: NCT02530541 ↗

Enrolled (actual)

126

Serious AEs

0.0%

Results posted

Apr 2021

Primary outcome: Primary: Log Reduction of Bacterial Flora on the Abdomen and Groin — 1.9; 2.0; 1.3; 1.9 Log10 Reductions

Study Design & Population

Study type: Interventional
Phase: Phase 2
Interventions: CHG (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Medline Industries
Primary completion: Jul 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Log Reduction of Bacterial Flora on the Abdomen and Groin	1.9; 2.0; 1.3; 1.9; 2.4; 2.1	—

Summary

Pilot study to evaluate and compare activity of preoperative preparation with comparator

Eligibility Criteria

Inclusion Criteria

Healthy
No dermatological conditions

Exclusion Criteria

Sensitivity to CHG
Sensitivity to natural latex rubber or adhesive skin products

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02530541). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.